Neurogene grants new employee stock options for 2,010 shares
NGNE•Neurogene granted one new employee options to purchase 2,010 common shares on November 3, 2026, under its 2025 Inducement Plan.
1. Option award terms
The options vest over four years, subject to continued employment. Vesting begins with 25% on the first anniversary of the vesting commencement date, followed by monthly vesting of 1/48 of the total award over the next three years.
